← Leaderboards
Susan F Dagher
Phasebio Pharmaceuticals, Inc.
$692,352
Attributed
$692,352
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $434.4K · FY2006–07$500K$375K$250K$125K$0
'06
'07
Funding mix
By agency
NIH$692,352 · 2
By mechanism
R44$592,352 · 1
R43$100,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Angiostatins”
- Donald W. Kufe · Dana-Farber Cancer Inst$4,245,680
- Selvarangan Ponnazhagan · University Of Alabama At Birmingham$2,743,761
- Bruce R Zetter · Children'S Hospital Boston$2,530,989
- Francis J Castellino · University Of Notre Dame$2,431,587
- Dimitri T. Azar · Schepens Eye Research Institute$2,221,983
- Dorothee Weihrauch · Medical College Of Wisconsin$2,163,563
Research focus
AngiostatinsBaseBehaviorBiopolymersBuffersCellsCentrifugationChimeric ProteinsChinese PeopleChromatographyClassCleaved CellColony-Stimulating FactorsConceptConditionCostDesignDrug CostsElastinEndopeptidasesErythropoietinEscherichia ColiExhibitsAlteplase